Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

A comparison between recipients receiving matched kidney and those receiving mismatched kidney from the same cadaver donor

Go back to Resources

A comparison between recipients receiving matched kidney and those receiving mismatched kidney from the same cadaver donor

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Untitled

Go back to Resources

Untitled

Authors:

Location:

Go back to Resources

Trial-related discrimination in HIV vaccine clinical trials

Go back to Resources

Trial-related discrimination in HIV vaccine clinical trials

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The relationship between underlying renal disease and renal transplantation outcome

Go back to Resources

The relationship between underlying renal disease and renal transplantation outcome

Authors:

Secondary:

Pagination:

Go back to Resources

The COBLT Study cord blood banking experience: donor recruitment, collection, processing, testing, and banking

Go back to Resources

The COBLT Study cord blood banking experience: donor recruitment, collection, processing, testing, and banking

Authors:

Location:

Go back to Resources

The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: The Age-Related Eye Disease Study Report Number 6

Go back to Resources

The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: The Age-Related Eye Disease Study Report Number 6

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS Report No. 4

Go back to Resources

The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS Report No. 4

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The Effect of Antibody Induction in Simultaneous Pancreas Kidney (SPK) Transplant Patients Receiving Tacrolimus (TAC) and Mycophenolate Mofetil (MMF): Two-Year Results

Go back to Resources

The Effect of Antibody Induction in Simultaneous Pancreas Kidney (SPK) Transplant Patients Receiving Tacrolimus (TAC) and Mycophenolate Mofetil (MMF): Two-Year Results

Authors:

Location:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 128
  • Page 129
  • Page 130
  • Page 131
  • Current page 132
  • Page 133
  • Page 134
  • Page 135
  • Page 136
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions